Premium
Phosphoramidon inhibits the generation of endothelin‐1 from exogenously applied big endothelin‐1 in cultured vascular endothelial cells and smooth muscle cells
Author(s) -
Ikegawa Ruriko,
Matsumura Yasuo,
Tsukahara Yaeko,
Takaoka Masanori,
Morimoto Shiro
Publication year - 1991
Publication title -
febs letters
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.593
H-Index - 257
eISSN - 1873-3468
pISSN - 0014-5793
DOI - 10.1016/0014-5793(91)81149-3
Subject(s) - phosphoramidon , endogeny , vascular smooth muscle , endothelin receptor , endothelin 1 , chemistry , extracellular , biology , microbiology and biotechnology , medicine , biochemistry , endocrinology , smooth muscle , receptor
When cultured porcine aortic endothelial cells (ECs) were incubated with porcine big endothelin‐1 (bit ET‐I 1–39 ), there was a time‐dependent increase in immunoreactive (IR)‐ET in the culture supernatant, in addition to an endogenous IR‐ET release fron the cells. Reverse‐phase HPLC of the culture supernatant revealed one major IR‐ET component corresponding to the elution position of synthetic ET‐1, thereby indicating that the additional increase in IR‐ET was due to the conversion of big ET‐1 to mature ET‐1 1–21 . Phosphoramidon, a metalloproteinase inhibitor, strongly suppressed this increase in IR‐ET as well as the endogenous IR‐ET release. Cultured vascular smooth muscle cells (VSMCs) also released IR‐ET. The apparent conversion of exogenously applied big ET‐1 to ET‐1 and its inhibition by phosphoramidon were observed using cultured VSMCs, although the enzyme inhibitor did not influence the basal secretion of IR‐ET from VSMCs. These results suggest that both cultured ECs and VSMCs can generate ET‐1 from exogenously applied big ET‐1 via action of the same type of phosphoramidon‐sensitive metalloproteinase, which is also involved in the endogenous ET‐1 generation in ECs.